Cargando…
VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease
Interstitial lung disease (ILD) encompasses a group of heterogeneous diseases characterised by varying degrees of aberrant inflammation and fibrosis of the lung parenchyma. This may occur in isolation, such as in idiopathic pulmonary fibrosis (IPF) or as part of a wider disease process affecting mul...
Autores principales: | Barratt, Shaney L., Flower, Victoria A., Pauling, John D., Millar, Ann B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983653/ https://www.ncbi.nlm.nih.gov/pubmed/29695053 http://dx.doi.org/10.3390/ijms19051269 |
Ejemplares similares
-
VEGF isoforms have differential effects on permeability of human pulmonary microvascular endothelial cells
por: Ourradi, Khadija, et al.
Publicado: (2017) -
Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial
por: Creamer, Andrew W., et al.
Publicado: (2019) -
The prognostic value of cardiopulmonary exercise testing in interstitial lung disease: a systematic review
por: Barratt, Shaney L., et al.
Publicado: (2020) -
Vascular Endothelial Growth Factor (VEGF) isoform expression and activity in human and murine lung injury
por: Medford, Andrew RL, et al.
Publicado: (2009) -
Sequestration of Vascular Endothelial Growth Factor (VEGF) Induces Late Restrictive Lung Disease
por: Wieck, Minna M., et al.
Publicado: (2016)